Psyched Wellness has contracted with a Lithuanian company to obtain 200 kgs of Amanita muscaria mushroom caps.
Psyched Wellness has contracted with a Lithuanian company to obtain 200 kgs of Amanita muscaria mushroom caps.
Novamind is doubling its Cedar Psychiatry network from four to eight locations, estimating a 325% increase in patient visits.
Field Trip announces the opening of its 5th new U.S. mental health clinic in Houston.
Mydecine reports that it's Phase IIa clinical trial is underway at three sites. Net loss for the year of CAD$26.9 million. Current cash ~CAD$30 million.
Numinus reports its Q2 2021 results. Cash balance of CAD$28.5 million. Net loss of CAD$4.2 million.
MindMed Inc has become the first psychedelics company to successfully uplist to the NASDAQ. Who will be the second...???
UK-based Small Pharma Inc prepares to go public on the TSXV via RTO, having raised CAD$58 million for its qualifying transaction
MINDCURE updates investors on key elements of its business model, including its iSTRYM digital therapeutics platform and its emerging TBI research.
Wesana Health obtains conditional approval from the CSE to commence trading, via RTO with Debut Diamonds (CSE:DDI).
Compass Pathways plans to issue 4,000,000 new shares via prospectus, with an option to sell an additional 600,000 shares.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now